Vidhi Specialty Food Ingredients Ltd
Vidhi Specialty Food Ingredients Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #32 of 71 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
The company anticipates a significant shift towards high-value products, aiming to increase their revenue share from 15% to around 50% over the next 3-5 years, which will drive better sales realization and margin improvement. The company anticipates improved margins driven by a shift towards high-value, complex products with gross margins above 50%.
From Vidhi Specialty Food Ingredients Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company anticipates a significant shift towards high-value products, aiming to increase their revenue share from 15% to around 50% over the next 3-5 years, which will drive better sales realization and margin improvement.
- Revenue from new complex products under R&D commercialization is expected to grow steadily over the next 6-8 quarters.
- Volume capacity utilization at Dahej plant is at 65-70% and expected to reach full utilization by end of the year, supporting volume growth.
- New capex plans at Dahej and Roha with a combined anticipated outlay of around INR100 crores will expand capacity and product portfolio, potentially enhancing future sales.
2 more points from Vidhi Specialty Food Ingredients Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Vidhi Specialty Food Ingredients Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current anticipated capex outlay for Dahej and Roha plants combined is around INR 100 crores.
- Already spent: INR 18 crores at Dahej (land acquisition) and approx. INR 15 crores at Roha.
- Additional capex of INR 100 crores planned for these two facilities.
- Capex activity at Roha includes a 4.5-acre land site, with pollution board approval received; construction to start within 2.5-3 months.
- Capex at Dahej involves a newly acquired 16,894 sq. meters (4.5 acres) land, with necessary government permissions being obtained.
- Engineering work ongoing; construction expected to complete within approximately 10 months at Roha.
- No immediate capex planned for de-bottlenecking or replacing machinery at older plants.
- Capex will be funded through a mix of internal accruals and some debt.
2 more points from Vidhi Specialty Food Ingredients Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Vidhi Specialty Food Ingredients Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Vidhi Specialty Food Ingredients Ltd said on order book & pipeline — free account, 30 seconds.
Vidhi Specialty Food Ingredients Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹137 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vidhi Specialty Food Ingredients Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Gujarat Alkalies (Q2 FY26)
2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against
- Dynemic Products Ltd (Q2 FY26)
Quarterly revenue for Q2 FY 25-26: ₹8,935 lakhs (Page 12, 10, 5) . Key investor presentation takeaways from Dynemic Products's Q2 FY26 investor presentation — a
- Platinum Industries Ltd (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
- IVP Ltd (Q2 FY26)
Revenue from Operations for Q2FY26: ₹146.95 crores . Key investor presentation takeaways from IVP's Q2 FY26 investor presentation — and how it ranks against sec
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Vidhi Specialty Food Ingredients Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Vidhi Specialty Food Ingredients Ltd Q2 FY26 results?
The company anticipates a significant shift towards high-value products, aiming to increase their revenue share from 15% to around 50% over the next 3-5 years, which will drive better sales realization and margin improvement. The company anticipates improved margins driven by a shift towards high-value, complex products with gross margins above 50%.
What is Vidhi Specialty Food Ingredients Ltd share price analysis?
Vidhi Specialty Food Ingredients Ltd currently shows a neutral. The stock trades at a P/E of 28.9 with a market cap of ₹1,548 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vidhi Specialty Food Ingredients Ltd planning capital expenditure?
Current anticipated capex outlay for Dahej and Roha plants combined is around INR 100 crores. - Already spent: INR 18 crores at Dahej (land acquisition) and approx.
Keep Vidhi Specialty Food Ingredients Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
